FORT LAUDERDALE, Fla., Feb. 14, 2022 (GLOBE NEWSWIRE) — Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) for the Pure-Vu® EVS System. The new Pure-Vu EVS System is intended to improve speed of set-up, enhance navigation capabilities in tortuous anatomy, build upon the excellent cleansing capabilities of the Pure-Vu system and enable physicians to rapidly overcome the challenges…
Author: Praveen Suthrum
At Janssen, we have made major strides in the treatment of inflammatory bowel disease (IBD) in recent years, but we still have much to achieve for the many patients who either don’t respond or have lost response to therapy. In fact, an estimated 0.8 million patients living with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD) – chronic debilitating diseases that comprise IBD – are refractory or intolerant to current therapy, and only 10 percent of people with moderate to severe IBD are in clinical remission.1
Gastroparesis can be tricky to diagnose and treat, in part because its symptoms can be difficult to distinguish from functional dyspepsia. A new clinical practice update from the American Gastroenterological Association aims to help physicians treat medically refractory gastroparesis with practical advice stemming from expert opinion and a literature review.
Upper gastrointestinal (GI) bleeding is a severe acute disease associated with four main causes, namely, esophageal variceal bleeding, peptic ulcer (PU) bleeding, gastric cancer bleeding and acute erosive hemorrhagic gastritis, and prompt diagnosis and treatment are mandatory [1, 2]. In adults, a fish bone is the most common food-related foreign body [3, 4]. A fish bone can unfortunately pierce the left subclavian artery (LSA) and cause a pseudoaneurysm in rare cases, resulting in an LSA esophageal fistula [3, 5]. Arterioesophageal fistula are rare, but they can cause massive life-threatening bleeding [6, 7]. Here, we report an adult case of a mediastinal abscess corroding the…
The device, called the Endoculus, has been designed by a team at the Advanced Medical Technologies Laboratory (AMTL) at the University of Colorado in the United States. Professor Mark Rentschler, director of the AMTL, who leads the project, explained the current version of the device began in earnest in 2016 with PhD students Greg Formosa and Micah Prendergast advancing the mechanical and electronic design. It has now reached the stage of adding more autonomous capabilities and features to further the understanding of its capabilities as the team look to transition the project into a commercial product that is affordable and…
Use of digital cognitive behavioral intervention (dCBI) was associated with statistically and clinically significant improvement in anxiety and depression for up to 4 months in adult patients with functional gastrointestinal disorders (FGIDs), according to a study in Clinical and Translational Gastroenterology. Patients who were seen during routine care at an integrated behavioral neurogastroenterology clinic with symptoms of anxiety or depression were offered access to a health coach-enhanced dCBI app (RxWell); the app provides users with a brief skill-building intervention with techniques such as relaxation and cognitive reframing.
It’s currently estimated that 50 percent of IBD patients experience some form of joint stiffness, otherwise known as arthralgia. With so many patients being affected, how can you determine if it’s inflammatory or noninflammatory arthralgia and treat it appropriately? To find out, Dr. Neil Nandi speaks with Dr. Monica Schwartzman, assistant attending physician at the Hospital for Special Surgery and Clinical Instructor of Medicine at Weill Cornell Medical College. Together, they’ll discuss the screening tools gastroenterologists can use to differentiate the types of arthralgia in their patients as well as key management approaches.
The FDA has granted investigational device exemption to medical diagnostics company Check-Cap for a two-part pivotal study to evaluate C-Scan, a new screening test that detects precancerous polyps. “There is a serious unmet need for a patient-friendly screening option that can overcome screening barriers while also enabling precancerous polyp detection. Most patient-friendly [colorectal cancer (CRC)] screening tests currently available or poised to enter the market, such as liquid biopsy or fecal tests, are primarily designed to detect cancer.
The lowering of the colorectal cancer screening age and the acceleration of the outpatient migration leaves gastroenterology ASCs and endoscopy centers primed for growth. Three gastroenterology leaders joined Becker’s to discuss tips for ASCs to thrive in competitive markets. Four tips: 1. Creating cost savings and quality controls Gabriel Ionescu, MD. Gastroenterologist at Wyckoff Heights Medical Center (New York City): ASCs will have to push for more procedures by creating cost savings and improving quality controls (i.e., shifting gastrointestinal cases to high-volume gastroenterologists with good quality benchmarks records). It is anticipated that lowering the colorectal cancer screening age will be beneficial to the…
The gastroenterology sector continued to experience rapid consolidation in the fourth quarter in 2021, according to a market update from Provident. Below are some select transactions from the gastroenterology sector during the fourth quarter: December Gastro Health acquired Gastroenterology Associates of Pensacola. The target has eight physicians in 17 locations across two states.